PHIOGEN has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle chronic and life-threatening infections

Houston, Texas
Joined August 2022
We are thrilled to shared PHIOGEN has been awarded a $1.1 M grant from CARB-X to further develop our first-in-class dual-action therapeutics that treat and prevent recurrent infections!
Replying to @CARB_X
@CARB_X has awarded @PHIOGEN US$1.1M to evaluate PHI-BI-01, its novel, dual-action therapeutic designed to treat and prevent ExPEC bloodstream infections, particularly those caused by multidrug-resistant strains. 🔗 Read here: bit.ly/41eNClc
2
90
PHIOGEN retweeted
@CARB_X has awarded @PHIOGEN US$1.1M to evaluate PHI-BI-01, its novel, dual-action therapeutic designed to treat and prevent ExPEC bloodstream infections, particularly those caused by multidrug-resistant strains. 🔗 Read here: bit.ly/41eNClc
2
2
1
6
239
Our team just applied to Startup World Cup @SWC2023 #CompanyName #StartupWorldCup @SWCPTV
100